0
Skip to Content
PAREA
PAREA
Home
About ⌄
About
Members
Meet the Team
Learn ⌄
Why
FAQs
Governance ⌄
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
MEP Action Group ⌄
About
Members
Events
Latest ⌄
News
Events
Videos
Support Us
PAREA
PAREA
Home
About ⌄
About
Members
Meet the Team
Learn ⌄
Why
FAQs
Governance ⌄
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
MEP Action Group ⌄
About
Members
Events
Latest ⌄
News
Events
Videos
Support Us
Home
Folder: About ⌄
Back
About
Members
Meet the Team
Folder: Learn ⌄
Back
Why
FAQs
Folder: Governance ⌄
Back
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
Folder: MEP Action Group ⌄
Back
About
Members
Events
Folder: Latest ⌄
Back
News
Events
Videos
Support Us
  • Testimonies,
• 08/09/2022

Dave Pounds - MDMA for Alcohol Use Disorder

Dave Pounds was a participant in AWAKN Life Science's Clinical Trial - MDMA for Alcohol Use Disorder
Previous

Launch of the Psychedelic Access and Research European Alliance

Next

Webinar: Overcoming Roadblocks Making Psychedelic-Assisted Therapy a Reality

You Might Also Like

Related Embedded Video Item Thumbnail Ongoing trials investigating psychedelic-assisted therapies
Related Embedded Video Item Thumbnail SA TAIP seminar | "Models for psychedelic assisted therapies: the needs and the solutions"
Related Embedded Video Item Thumbnail The importance of mental health | Tadeusz Hawrot - TVP World
Related Embedded Video Item Thumbnail Launch of the PsychedeliCare and MEP Action Group on Psychedelics in Healthcare at the European Parliament 06.02.2025
Related Embedded Video Item Thumbnail Psychedelic-assisted therapies in the treatment of brain disorders - European Parliament

Contact

tadeusz@parea.eu

Our Work

About
Why

© Parea 2024 | Privacy Policy